• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US CORAIL2 LAT COXA VARA SIZE 11; CORAIL AMT CEMENTLESS IMPLANT : HIP FEMORAL STEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US CORAIL2 LAT COXA VARA SIZE 11; CORAIL AMT CEMENTLESS IMPLANT : HIP FEMORAL STEM Back to Search Results
Catalog Number 3L93711
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code Fall (1848)
Date of Event 02/26/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
It was reported that the patient underwent a right hip arthroplasty in (b)(6) 2020, followed by a surgical revision due to dislocation with head change in december.On (b)(6) 2024, tripping fall with fracture of the prosthesis neck of the inserted corail hip stem.Surgical revision with stem replacement on (b)(6) 2024.
 
Additional Manufacturer Narrative
Product complaint (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information, which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained, that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint #(b)(4).Investigation summary: according to the information received: "hcp is reporting to nca/bfarm: "patient underwent a right hip arthroplasty in (b)(6) 2020, followed by a surgical revision due to dislocation with head change in (b)(6).On (b)(6) 2024, tripping fall with fracture of the prosthesis neck of the inserted corail hip stem.Surgical revision with stem replacement on (b)(6) 2024".The product was not returned to depuy synthes, however photos were provided for review.The photo investigation revealed the neck of corail2 lat coxa vara size 11 fractured.Additionally, a cup liner and a competitor femoral head can be observed on provided evidence.Per ifu w90918 rev.C, the following precautions must be followed: "implants and trial components from different manufacturers or implant systems should never be used together"; "use only depuy modular femoral heads with depuy femoral stems.The taper of the femoral head must match the taper of the femoral stem"; "please refer to the surgical technique guide for a listing of compatible components".With the information provided is not possible to determine a potential cause at this moment.The mode of failure of the device is multi-factorial and consideration must be given to all other potential influences such as surgical process, patient variables (e.G.Activity level and use), anatomical considerations, functionality of competitors devices and patient changes over time.Since the device was not returned, a dimensional inspection cannot be performed.The overall complaint was confirmed as the observed condition of the corail2 lat coxa vara size 11 would contribute to the complained device issue.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.There is no indication that a design or manufacturing issue has caused the complaint condition.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot: quantity manufactured: (b)(4); date of manufacture: 21/jul/2020; any anomalies or deviations identified in dhr: no; expiry date: 30/jun/2025; ifu reference: ifu-w90918.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CORAIL2 LAT COXA VARA SIZE 11
Common Device Name
CORAIL AMT CEMENTLESS IMPLANT : HIP FEMORAL STEM
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
JTE WARSAW MFG SITE
700 orthopaedic drive
warsaw IN
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key18902347
Report Number1818910-2024-05768
Device Sequence Number7839444
Product Code LZO
UDI-Device Identifier10603295168881
UDI-Public10603295168881
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K192946
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/30/2025
Device Catalogue Number3L93711
Device Lot Number5368189
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/04/2024
Supplement Date Received by Manufacturer03/14/2024
05/13/2024
Initial Report FDA Received Date03/14/2024
Supplement Report FDA Received Date03/19/2024
05/14/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/21/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-